Micrus Shares Up As Analyst Rates It 'outperform'
NEW YORK (AP) ¿ Shares of Micrus Endovascular Corp. rose Friday after an analyst began covering the medical device maker with an "outperform" rating.
Micrus develops and sells products intended to treat vascular problems in the brain. Robert W. Baird and Co. analyst Lawrence Neibor said Micrus is the largest company focused entirely on the neurological market, and its sales are growing much faster than the overall market.
The analyst added that Micrus is taking market share from larger competitor Boston Scientific Corp., making it the second largest neurovascular company, and hopes to enter the Chinese market soon. He said the San Jose, Calif., company will start selling new products over the next two years, including stents, catheters and wires for electronic devices, that will boost its revenue.
Neibor set a price target of $14 per Micrus share, and in afternoon trading the stock was up 26 cents, or 2.2 percent, to $12.19 after touching $12.41 earlier in the session.
Shares of Micrus have traded between $4.13 and $15 over the last year, but the stock last traded at $14 on Oct. 2, 2008.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
